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Abstract Bacillus subtilis is a well-established cellular
factory for proteins and fine chemicals. In particular, the
direct secretion of proteinaceous products into the growth
medium greatly facilitates their downstream processing,
which is an important advantage of B. subtilis over other
biotechnological production hosts, such as Escherichia coli.
The application spectrum of B. subtilis is, however, often
confined to proteins from Bacillus or closely related
species. One of the major reasons for this (current)
limitation is the inefficient formation of disulfide bonds,
which are found in many, especially eukaryotic, proteins.
Future exploitation of B. subtilis to fulfill the ever-growing
demand for pharmaceutical and other high-value proteins
will therefore depend on overcoming this particular hurdle.
Recently, promising advances in this area have been
achieved, which focus attention on the need to modulate
the cellular levels and activity of thiol-disulfide oxidor-
e d u c t a s e s( T D O R s ) .T h e s eT D O R sa r ee n z y m e st h a t
control the cleavage or formation of disulfide bonds. This
review will discuss readily applicable approaches for
TDOR modulation and aims to provide leads for further
improvement of the Bacillus cell factory for production of
disulfide bond-containing proteins.
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Protein production
Proteins are the key operators and driving force of all
cellular activity (Alberts et al. 2008). In the last decades
there has been a clear trend towards direct commercial
production of specific proteins of interest that show
desired biological activities. These protein products range
from enzymes for household detergents and textile clean-
ing to food enzymes, antibiotics, and pharmaceuticals
(Meima et al. 2004; Schallmey et al. 2004; Zeigler and
Perkins 2008). The ability to produce these products is
thus an important prerequisite for many industrial and
medical applications. Although peptides and proteins can
be synthesized chemically, this is in many cases not an
option for commercial production due to high costs and
technical limitations. An excellent alternative to circum-
vent this problem is the use of microorganisms as cell-
based factories. In this approach, microorganisms are
selected or genetically modified to enable and optimize
the production of a particular protein of interest. There are
various microbial cell factories used in industry, the most
common ones being the yeast Saccharomyces cerevisiae,
the fungus Aspergillus niger and the bacteria Escherichia
coli and Bacillus subtilis. Each of these microorganisms
has a good track record for protein production. Therefore,
the choice of the production host is often determined by
specific characteristics of the protein that needs to be
produced. This minireview focuses on the use of B.
subtilis as a cell factory, with special emphasis on
d i s u l f i d eb o n df o r m a t i o ni ns e c r e t e dp r o t e i n s .
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The Gram-positive bacterium B. subtilis naturally thrives in
the soil and the plant rhizosphere where it feeds on
decaying plant material (Earl et al. 2008). To facilitate
these breakdown processes, it produces and secretes a wide
variety of enzymes, such as proteases, amylases, and
lipases, of which many have found industrial applications.
Importantly, B. subtilis is able to produce these enzymes in
high amounts and to secrete them directly into the growth
medium. Accordingly, the majority of B. subtilis proteins
that are transported across the cytoplasmic membrane end
up directly in the extracellular milieu (Tjalsma et al. 2000;
van Wely et al. 2001). This is in marked contrast to Gram-
negative bacteria, such as E. coli, which have an outer
membrane that retains many proteins in the periplasm. The
high capacity for protein secretion makes B. subtilis an
extremely attractive organism to investigate the total flow
of proteins from the cell into the environment by proteomic
techniques, and greatly facilitates the down-stream purifi-
cation in industrial protein productions (Antelmann et al.
2003; Tjalsma et al. 2004). Other useful aspects of B.
subtilis include its good fermentation capabilities, an
awarded Generally Recognized as Safe (GRAS) status by
the US food and drug administration and the great
amenability of this organism for genetic modification
studies (Chen et al. 2006; Dubnau and Lovett 2001). These
factors combined have triggered a substantial amount of
research on B. subtilis in the last decades, and they have
made this organism a paradigm for applied research on
protein secretion mechanisms and a popular host for
industrial protein production (Bron et al. 1999; Meima et
al. 2004; Zeigler and Perkins 2008).
Product folding and stability
Despite the extensive use of B. subtilis for biotechnological
purposes, its deployment in protein production is largely
limited to homologous proteins, since several bottlenecks in
the use of B. subtilis for heterologous protein production
still exist. These complications can relate to: (1) inefficient
targeting and translocation of the foreign proteins to and
across the plasma membrane, (2) inefficient posttransloca-
tional folding and release of the exported proteins from the
cell surface into the surrounding medium, and (3) degrada-
tion of the secreted proteins (Meens et al. 1997; Puohiniemi
et al. 1992; Saunders et al. 1987; Bolhuis et al. 1999a;
Brockmeier et al. 2006). Product degradation still remains a
major potential complication, especially in the use of B.
subtilis for heterologous protein production. Due to its
innate ability to produce and secrete multiple proteases, the
extracellular environment of B. subtilis is highly proteolytic
(Craddock et al. 2008). Consequently, unfolded or incor-
rectly folded exported proteins are very quickly degraded
before they have a chance to (re)fold into their correct,
protease-resistant conformation (Westers et al. 2006a). This
is especially problematic for complex recombinant proteins,
which often fold only slowly. The issue can to some extent
be resolved by using either protease-deficient strains (Wu et
al. 1991, 1993; Ye et al. 1999), or by addition of protease
inhibitors to B. subtilis cultures, as was shown recently for
the pharmaceutically relevant recombinant protein human
Interleukin-3 (hIL-3; (Westers et al. 2006b, 2008)). How-
ever, there seems to be a limit to the level of degradation
that can be prevented by such methods and it also raises
other possible complications, such as the use of undesirable
and/or expensive growth medium additives, and the
accumulation of unwanted proteins of B. subtilis that would
otherwise be degraded by the secreted proteases (Westers et
al. 2008). Furthermore, although the final protein yields
obtained from such a strategy can be higher, a significant
fraction of these proteins may not be correctly folded and
will therefore not display the desired biological activity. A
more constructive solution to these problems is, therefore,
to not only prevent the degradation of slowly folding or
unfolded high-value proteins, but also to facilitate a better
or faster folding of these proteins, which will render them
less vulnerable to proteolysis in a shorter period of time. In
turn, this will not only ensure that less of the produced
proteins are degraded upon production in B. subtilis, but it
will also guarantee the high quality of produced proteins for
which the Bacillus cell factory has a strong track record. In
order to achieve this ambitious goal, it is necessary to know
why many heterologous proteins actually fold slowly or
incorrectly in B. subtilis. In the case of proteins with
disulfide bonds, this focuses attention on the mechanism of
disulfide bond formation in this organism.
Disulfide bonds
One of the most significant reasons why heterologous and
especially eukaryotic proteins often fold with difficulty in
B. subtilis is the inefficient formation of disulfide bonds
(Westers et al. 2004). Disulfide bonds consist of intra- or
intermolecular bridges that are formed during oxidation of
the thiol groups of two cysteine residues. These bonds play
an essential role in the correct folding and structural
integrity of numerous proteins found in nature. Importantly,
many eukaryotic proteins of biopharmaceutical interest
contain multiple disulfide bonds. Well known examples
include human insulin, insulin-like growth factor, human
growth hormone, brain-derived neutrophic factor, nerve
growth factor, lipases, Bowman–Birk protease inhibitor,
and antibody fragments (Wu et al. 1998; Hoshino et al.
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correct thiol-oxidation that links their cysteines into
disulfide bonds, these proteins will neither be fully stable
nor active (Collet and Bardwell 2002; Ritz and Beckwith
2001). Heterologously produced proteins in B. subtilis in
which the disulfide bonds have not been correctly formed
are thus quickly degraded. The selection of a cellular host
strain capable of efficient and correct formation of disulfide
bonds is therefore an important consideration for heterolo-
gous protein production.
Unfortunately, B. subtilis appears not to be very efficient
in the formation of disulfide bonds in its exported proteins
(Westers et al. 2004), as was underpinned by the heterolo-
gous production of the disulfide bond containing E. coli
alkaline phosphatase PhoA (Darmon et al. 2006; Bolhuis et
al. 1999b). Although B. subtilis was able to produce and
secrete this protein in high amounts into the growth medium,
a large fraction was not correctly folded and quickly
degraded. Accordingly, the PhoA-producing cells displayed
a so-called secretion stress response, which was exacerbated
in the absence of appropriate thiol-disulfide oxidoreductases
that are needed for posttranslocational PhoA folding
(Darmon et al. 2006). This suggested that a possible solution
for overcoming problems in the production of proteins with
disulfide bonds should be sought in increasing the capacity
of B. subtilis for disulfide bond formation.
Thiol-disulfide oxidoreductases
For a long time, the formation of disulfide bonds was
believed to occur spontaneously. Spontaneous oxidation of
thiol-groups into disulfide bonds does indeed occur, but this
process is very slow and nonspecific (Anfinsen 1973). For
this reason, enzymes called thiol-disulfide oxidoreductases
(TDORs) have evolved that catalyzes the formation (oxida-
tion) of disulfide bonds in vivo. Notably, the TDORs also
include enzymes that break (reduce) or isomerize disulfide
bonds. In essence, these enzymes transfer disulfide bonds to
or from their substrates in thiol-disulfide exchange reactions.
Cytoplasmic TDORs generally function as reductases while
their extra-cytoplasmic equivalents are oxidases or iso-
merases (Dorenbos et al. 2005; Tan and Bardwell 2004;
Ritz and Beckwith 2001; Kouwen and van Dijl 2009). Well
known examples of TDORs are the generally conserved
cellular reductase TrxA (Holmgren 1985), the eukaryotic
protein disulfide isomerase (Sevier and Kaiser 2006), and the
Dsb proteins in E. coli (Heras et al. 2007;K a d o k u r ae ta l .
2003;N a k a m o t oa n dB a r d w e l l2004). These TDORs are part
of the complex TDOR machinery responsible for handling
disulfide bonds in the proteins of the respective organisms.
Whereas disulfide bonds are a common feature of many
eukaryotic proteins, only few disulfide-bond containing
proteins have thus far been identified in B. subtilis despite
intensive bioinformatic and proteome-wide searches (Dutton
et al. 2008;S a r v a se ta l .2004; Tjalsma et al. 2004). This
could suggest that B. subtilis did not encounter the
evolutionary selective pressure to develop a complex TDOR
system. Nevertheless, several TDORs have been identified in
B. subtilis (Table 1). These were named Bdb proteins for
Bacillus disulfide bond formation (Ishihara et al. 1995). The
B. subtilis BdbD protein is regarded as the major extrac-
ytoplasmic thiol oxidase, which is kept in and oxidized state
by the paralogous quinone reductases BdbB and BdbC, with
a major role for BdbC in this process. The BdbD–BdbBC
system thus resembles the DsbA–DsbB system in E. coli,
Table 1 Thiol-disulfide oxidoreductases described in this paper
Organism Gene Product Reference
Bacillus subtilis bdbB Membrane-embedded thiol oxidase/quinone reductase
(Bacillus disulfide bond protein B)
(Dorenbos et al. 2002)
bdbC Membrane-embedded thiol oxidase/quinone reductase
(Bacillus disulfide bond protein C)
(Bolhuis et al. 1999b)
bdbD Membrane-associated extracytoplasmic thiol oxidase
(Bacillus disulfide bond protein C)
(Meima et al. 2002)
ccdA Membrane-embedded disulfide reductase
(cytochrome c deficiency protein A)
(Schiott et al. 1997)
resA Membrane-associated extracytoplasmic disulfide reductase
(respiratory protein A)
(Erlendsson et al. 2003)
stoA (spoIVH) Membrane-associated extracytoplasmic disulfide reductase
(sporulation thiol-disulfide oxidoreductase A)
(Erlendsson et al. 2004)
trxA Cytoplasmic disulfide reductase (thioredoxin A) (Kouwen et al. 2008)
yneN (catA) Predicted membrane-associated extracytoplasmic TDOR
(CcdA associated TDOR)
(Kouwen and van Dijl 2009)
Staphylococcus aureus dsbA Membrane-associated extracytoplasmic thiol oxidase
(disulfide bond protein A)
(Dumoulin et al. 2005)
Brevibacillus choshinensis catA CcdA-associated TDOR (Tanaka et al. 2003)
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studies on the secretion of the heterologous disulfide bond-
containing protein PhoA of E. coli by B. subtilis revealed
that BdbB, BdbC, and BdbD contribute to the folding of
exported PhoA into a stable and active conformation
(Bolhuis et al. 1999b;D o r e n b o se ta l .2002; Meima et al.
2002). BdbB, bdbC or bdbD mutant strains secreted
significantly lower amounts of active PhoA than the parental
strain 168. Since the rates of synthesis and signal peptide
processing of the PhoA precursor were not negatively
affected in bdb mutant strains, it was concluded that this
protein was degraded after membrane translocation due to a
folding defect that was caused by the absence of the different
Bdb proteins. Most likely, this folding defect would relate to
ineffective disulfide bond formation. Notably, however,
substantial amounts of overexpressed PhoA were also
degraded in the Bdb proficient parental strain 168, indicating
that the activity of TDORs such as BdbBCD might be
limiting in B. subtilis (Darmon et al. 2006; Kouwen et al.
2008). Based on these findings, several strategies were
developed to overcome the apparent TDOR limitation. These
are schematically represented in Fig. 1 and will be discussed
in the following sections.
Overexpression of (heterologous) oxidative TDORs
The production of secretory proteins at high levels may
result in a saturation of the cellular machinery of B. subtilis
that is required for the secretion and subsequent folding of
these proteins (Hyyrylainen et al. 2001; Sarvas et al. 2004).
This might apply also to the availability of Bdb proteins in
cells overproducing the E. coli PhoA protein or other
proteins with multiple disulfide bonds. The most straight-
forward solution to overcome this bottleneck would be to
produce oxidative TDORs at elevated levels, and in concert
with the produced heterologous proteins. Indeed, such
attempts have previously been made with the Bdb proteins
(Darmon et al. 2006; Kouwen et al. 2007). This however
did not result in improved protein folding and secretion of
E. coli PhoA. Even the combined expression of different
Bdb proteins was shown to have no beneficial effects on
PhoA production (our unpublished observations). One
possible explanation for this might be that another non-
overexpressed TDOR of the oxidative pathway was still a
limiting factor. Also it turned out difficult to overproduce
the B. subtilis Bdb proteins in B. subtilis (Kouwen et al.
2007). Therefore, the possibility of expressing heterologous
oxidases in B. subtilis was recently investigated (Kouwen et
al. 2008). The oxidative TDOR DsbA of Staphylococcus
aureus seemed a good candidate for this purpose since this
homologue of B. subtilis BdbD was shown to be one of the
strongest thiol oxidases known (Dumoulin et al. 2005).
Expression of the S. aureus DsbA in B. subtilis was shown
to complement for the loss of both BdbC and BdbD in the
secretion of active PhoA (Kouwen et al. 2007). Interest-
ingly, when S. aureus DsbA was expressed in Bdb
proficient B. subtilis 168, an increase in the secretion of
Fig. 1 Schematic representation of different strategies for improved
disulfide bond formation in B. subtilis. The diagram shows known
TDORS and their respective subcellular topologies. Optimized
disulfide bond formation can already be achieved by: (1) introduction
of strong thiol-oxidases like staphylococcal DsbA, (2) depletion of the
cytoplasmic disulfide reductase TrxA, and (3) addition of redox-active
compounds to the growth medium. Further improvement can possibly
be achieved by (4) the modulation of the yet hypothetical CcdA–
YneN pathway for disulfide isomerization in B. subtilis as was
described for B. choshinensis. Dashed arrows indicate the flow of
electrons. The large gray arrows indicate protein export from the
cytoplasm. See text for further details
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and, at the same time, less PhoA degradation was
detectable. This therefore seems a useful strategy to
increase the potential of B. subtilis to produce proteins
with disulfide bonds. Notably, it may not be desirable to use
genes derived from pathogenic bacteria such as S. aureus
dsbA in the production of, in particular, pharmaceutical
proteins. To avoid this potential problem, the homologous
dsbA gene from the food-grade nonpathogenic bacterium
Staphylococcus carnosus was cloned and expressed in B.
subtilis (Kouwen et al. 2008). Like DsbA from S. aureus,
the S. carnosus DsbA allowed the secretion of active PhoA
at elevated levels. Evidently, the co-expression of appro-
priate TDORs with secreted disulfide bond-containing
proteins is a very promising route to be followed for
obtaining increased yields of correctly folded proteins with
disulfide bonds.
Depletion of reductive TDORs
An alternative strategy to achieve better folding of disulfide
bond-containing proteins through TDOR modulation is the
removal of inefficient or counter-productive TDORs. This
was shown by depleting the major reductive TDOR
thioredoxin A (TrxA) from the cytoplasm of cells produc-
ing E. coli PhoA, which resulted in the extracellular
accumulation of active PhoA at elevated levels (Kouwen
et al. 2008). Noteworthy though, the depletion of other
(potential) cytoplasmic or membrane-associated reductive
TDORs did not result in higher levels of active PhoA. The
finding that depletion of TrxA did contribute to a more
effective folding of PhoA was actually counter-intuitive
since TrxA is a cytoplasmic protein while PhoA folding and
disulfide bond formation take place after export from the
cytoplasm at the trans side of the membrane. An explana-
tion was found when the redox state of BdbD under
conditions of TrxA limitation was examined (Kouwen et al.
2008). The depletion of TrxA was shown to result in
relatively higher levels of oxidized BdbD. On the contrary,
the absence of the quinone reductase BdbC resulted in high
levels of reduced BdbD, which is consistent with the fact
that mutation of bdbC resulted in impaired PhoA folding
(Bolhuis et al. 1999b; Kouwen et al. 2008; Meima et al.
2002). A bdbC mutation was dominant over the effects of
TrxA depletion. Taken together, these findings show that
the cytoplasmic reductase TrxA has an impact on the redox
state of extracytoplasmic BdbD in a BdbC-dependent
manner. This implies that electron transfer from TrxA to
BdbC/BdbD can occur either directly from TrxA to BdbC
to BdbD, or indirectly through other as yet unidentified
components. Consistent with this idea, recent studies
indicate that TrxA is the primary electron donor to several
different TDORs that are active on the extracytoplasmic
side of the B. subtilis membrane (Moller and Hederstedt
2008). Minimization of this electron transfer route by
reduction of the cytoplasmic TrxA to levels that are
sufficient to sustain wild-type growth and cell viability will
thus result in relatively higher levels of BdbD proteins in an
oxidized state, which is necessary for improved oxidation
of substrate proteins with disulfide bonds. Possibly, further
optimization of the oxidative properties of B. subtilis can be
achieved once the cytoplasmic and extracytoplasmic TDOR
networks and their essential contact points in the cytoplas-
mic membrane have been elucidated. This would allow a
detailed fine-tuning of the electron transfer routes for
optimized recycling of BdbD to the oxidized state, thereby
facilitating fast and effective substrate oxidation.
Overexpression of isomerases
In E. coli, disulfide isomerases contribute significantly to
the final yield of correctly folded disulfide bond containing
proteins, by reoxidizing any incorrectly formed disulfide
bonds. In contrast to E. coli, disulfide isomerases, if at all
present, have so far remained undetected in B. subtilis
(Kouwen and van Dijl 2009). Clearly, B. subtilis lacks
obvious homologues of E. coli isomerases, such as DsbC or
DsbG. Nevertheless, B. subtilis does contain reductive
TDORs in the cytoplasmic membrane, which have been
shown to be involved in reducing apocytochrome c and
spore cortex proteins (Moller and Hederstedt 2006;
Erlendsson and Hederstedt 2002; Erlendsson et al. 2003).
Interestingly, the central TDOR in this reductive system,
CcdA, together with an associated TDOR (ResA or StoA),
represents a functional and structural homologue of the E.
coli DsbD TDOR, which transfers electrons to the
periplasmic disulfide isomerase DsbC (Katzen et al.
2002). Previously, the homologue of another CcdA-
associated TDOR, YneN (also known as CatA), was shown
to have protein disulfide oxidoreductase-like activity in
Brevibacillus choshinensis (Bacillus brevis). Incubation of
nonnative human epidermal growth factor (hEGF) contain-
ing incorrect disulfide bonds with B. choshinensis cells
overexpressing YneN, or coexpression of the two proteins,
increased the final yield of active hEGF praotein (Miyauchi
et al. 1999; Tanaka et al. 2003, 2005). However, coex-
pression or deletion of the B. subtilis YneN together with
the expression of E. coli PhoA by B. subtilis did not have
any detectable effect on the yield of active PhoA (our
unpublished observations). It thus remains to be shown
whether B. subtilis contains a system for protein disulfide
isomerization. An intriguing possibility is that the antago-
nistic effects of the reductive CcdA–ResA and oxidative
BdbCD pathways serve in the isomerization of disulfide
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subtilis can achieve disulfide isomerization by bringing
these pathways together, thereby overcoming the lack of
more dedicated disulfide isomerases such as DsbC and
DsbG of E. coli.
Addition of redox active compounds to the growth
medium
Instead of increasing the expression levels of oxidative
TDORs, it may also be possible to increase their activity for
substrate oxidation through enhanced reoxidation during
catalysis. Whereas the reoxidation rate of the oxidative
TDORs in B. subtilis seems to be determined by other
TDORs and their connection with the electron transfer
chain in the membrane, this does not seem to be the case in
certain other Gram-positive bacteria, such as S. aureus.
When expressed in B. subtilis, the activity of S. aureus
DsbA was found to depend completely on the presence of
redox active compounds in the growth medium (Kouwen et
al. 2007). Thus, the DsbA protein can achieve reoxidation
during catalysis by electron transfer to externally added
electron acceptors such as cystine, the oxidized form of
cysteine. This approach seemed an attractive option for
modulating the oxidative properties of B. subtilis strains
expressing the DsbA proteins of S. aureus or S. carnosus.
We therefore tested its applicability by adding increased
amounts of cystine to the growth media of B. subtilis cells
expressing these DsbA proteins. Indeed, enhanced extra-
cellular levels of folded and active E. coli PhoA were
observed when DsbA expressing strains were grown in the
presence of added cystine (Kouwen et al. 2008). It thus
seems that the addition of redox active compounds to the
growth medium is a realistic possibility to increase the
oxidative properties of engineered Bacillus host strains for
increased production of proteins with disulfide bonds.
Outlook—combining the different approaches
The proof-of-principle for the concept that TDOR modula-
tion can result in a significantly improved production of
proteins with disulfide bonds, such as E. coli PhoA, has
been obtained through the combined depletion of TrxA,
production of staphylococcal DsbA, and addition of
extracellular oxidative compounds that can accept electrons
from DsbA. In this case, up to four-fold increased levels of
active extracellular PhoA can be observed, indicating a
significant improvement of posttranslocational folding and
a concomitant reduction of posttranslocational PhoA
degradation (Kouwen et al. 2008). Importantly, hardly any
breakdown products of PhoA were observed under these
conditions, indicating that most of the PhoA was correctly
folded to a protease-resistant conformation. This indicates
that it should be possible to challenge and employ the
combined strategies described in this review for the
production of other useful proteins that contain disulfide
bonds as summarized in Fig. 1.
Following the chain of events in the synthesis and
secretion of proteins, we envisage several relevant and
timely activities. In the first place, the cytoplasmic TDOR
network and its impact on secreted disulfide bond-
containing proteins must be disentangled. In addition to
TrxA, there are at least seven other cytoplasmic TDORS
that potentially have a role in cytoplasmic disulfide
handling (YbdE, YdbP, YdfQ, YkuV, YosR, YtpP, and
Y u s E ;( E r l e n d s s o ne ta l .2004; Kouwen et al. 2008;
Kouwen and van Dijl 2009; Zhang et al. 2006)). While
no role for these TDORS has been established as yet, they
may impact on the production of proteins with disulfide
bonds under particular conditions, for example when the
level of TrxA is down-regulated. In this respect, it is
noteworthy that TrxA was originally identified as an
essential protein in B. subtilis (Kobayashi et al. 2003;
Scharf et al. 1998). Recent studies however, have shown
that TrxA is nonessential when the growth medium is
supplemented with cysteine, methionine, and deoxyribonu-
cleosides (Moller and Hederstedt 2008). This suggests that
there is further room for TDOR modulation in engineered
strains that lack TrxA. Like the cytoplasmic TDOR
network, the membrane and transmembrane TDOR net-
works deserve further investigation in relation to improving
the potential of B. subtilis for disulfide bond formation.
Next to BdbBCD, there are at least five TDORS (BdbA,
CcdA, ResA, StoA/SpoIVH, and YneN) that deserve closer
investigations with respect to their possible positive or
negative roles in extractyoplasmic disulfide bond formation
(Erlendsson et al. 2004; Kouwen et al. 2008;K o u w e na n d
van Dijl 2009; Zhang et al. 2006). Clearly, reducing the
reductive effects of the CcdA–ResA pathway, which is
known to be antagonistic to the BdbCD pathway (Erlendsson
and Hederstedt 2002) may be a way to achieve further
optimized reoxidation of BdbD during catalysis. Admittedly
however, our attempts so far to achieve this goal have not
been successful (unpublished observations), suggesting that
this cannot be done in a very straightforward manner.
Possibly, in combination with heterologous oxidases from
Staphylococcus species, the engineering of membrane-
associated TDORs of B. subtilis will yield applicable results.
If so, further progress can be achieved by identifying optimal
electron acceptors that can be added to the growth medium.
Such growth medium additives would, of course, need to be
nontoxic and cheap. Since these are all achievable goals, we
are convinced that a combined application and fine-tuning of
the strategies described in this review will soon allow
50 Appl Microbiol Biotechnol (2009) 85:45–52optimal use of the high production potential of B. subtilis for
high-value proteins with disulfide bonds.
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